Akebia Therapeutics Inc (AKBA.OQ)
* Akebia Therapeutics announces third quarter 2017 financial results
* Invirsa secures seed financing to develop new approach to treating common infectious diseases that affect millions annually Source text for Eikon: Further company coverage:
BOSTON, Oct 12 A former Akebia Therapeutics Inc employee accused of insider trading was released from jail on Thursday despite a judge's concern that the man's "Dr. Jekyll and Mr. Hyde" tendencies could lead him to violate his bail conditions.
BOSTON, Sept 22 A former Akebia Therapeutics Inc employee accused of insider trading was re-arrested on Friday after violating a bail condition as a prosecutor who once called him "increasingly unhinged" said he would seek the man's detention pending trial.
BOSTON, July 20 A former Akebia Therapeutics Inc employee accused of insider trading faced the growing possibility of having his bail revoked as a U.S. prosecutor argued on Thursday that he posed a flight risk and was growing "increasingly unhinged."
* Muneer Satter reports 6.48 percent stake in Akebia Therapeutics Inc as of July 5 - SEC filing
* Akebia Therapeutics announces proposed public offering of common stock